New Clinical Study Shows Masimo PVI(TM) Accurately Predicts Fluid Responsiveness in the ICUFirst Study to Expand PVI Utility Beyond the OR

Presented at the 29th International Symposium on Intensive Care and Emergency Medicine in Brussels

IRVINE, Calif., March 31 (HSMN NewsFeed) -- Masimo (Nasdaq: MASI ), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, announced today that a new independent clinical study demonstrates Masimo PVI to be an "accurate index of fluid responsiveness" for critical care patients in the intensive care unit (ICU).(1) The study, presented at the 29th International Symposium on Intensive Care and Emergency Medicine on March 25, 2009, in Brussels, Belgium, is the first to show the potential value of Masimo PVI to predict fluid responsiveness beyond the operating room (OR) into the ICU.

Full text >>